Seattle, WA, United States of America

Kelsey Hanson

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Proteotech Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kelsey Hanson. Retrieved from https://idiyas.com/inventor/kelsey-hanson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kelsey Hanson: Innovator in Caffeinated Compounds for Amyloid Diseases

Introduction

Kelsey Hanson is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of amyloid diseases and synucleinopathies. His innovative work focuses on caffeinated compounds that have the potential to address serious health conditions such as Alzheimer's and Parkinson's diseases.

Latest Patents

Kelsey Hanson holds a patent for "Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies." This patent includes compounds and their pharmaceutically acceptable salts aimed at treating β-amyloid diseases, which are commonly observed in Alzheimer's disease, as well as synucleinopathies like Parkinson's disease. He has 1 patent to his name, showcasing his dedication to advancing medical science.

Career Highlights

Throughout his career, Kelsey has worked with notable companies such as Proteotech Inc. and Protamed, Inc. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Kelsey has had the opportunity to work alongside talented individuals, including Luke A. Esposito and Marisa C. Yadon. Their collaborative efforts have further enhanced the impact of his research and innovations.

Conclusion

Kelsey Hanson is a notable inventor whose work in caffeinated compounds for treating amyloid diseases and synucleinopathies holds promise for future medical advancements. His contributions to the field reflect a commitment to improving health outcomes for individuals affected by these challenging conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…